WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
WORCESTER, Vermont
Total Received
$2.30B
Total Awards
1K
State
Vermont
Last Updated
Mar 20, 2026
Yearly Funding Trend
$1.88B24
$369.2M25
$50.0M26
Top 50 Awards to WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_UL1TR002384_075 CLINICAL AND TRANSLATIONAL SCIENCE CENTER - PROJECT SUMMARY/SUMMARY THE WEILL CORNELL MEDICINE CLINICAL AND TRANSLATIONAL SCIENCE CENTER’S (CTSC) FUTURE STRATEGIES ARE BUILT ON TH… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | NEW YORK, NY-12 | 2024 | $76,438,357 |
ASST_NON_UM1AI069419_075 WEILL CORNELL MEDICINE - RUTGERS NEW JERSEY MEDICAL SCHOOL CLINICAL TRIALS UNIT - PROJECT SUMMARY THE WEILL CORNELL MEDICINE – RUTGERS NEW JERSEY MEDICAL SCHOOL CLINICAL TRIALS UN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $42,844,978 |
ASST_NON_P01AI110657_075 CLEAVED, STABILIZED HIV-1 ENV TRIMERS FOR STRUCTURAL AND VACCINE STUDIES - OVERALL ABSTRACT THIS HIVRAD PROGRAM PROJECT RENEWAL APPLICATION IS MADE IN RESPONSE TO PAR-18-319. IT C… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $35,376,851 |
ASST_NON_T32GM007739_075 WEILL CORNELL/ROCKEFELLER/SLOAN KETTERING MST PROGRAM - PROJECT SUMMARY THE TRI-INSTITUTIONAL MD-PHD PROGRAM IS A JOINT UNDERTAKING OF WEILL CORNELL MEDICINE (WCM), THE ROCKEFELLE… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | NY-90 | 2025 | $34,004,945 |
ASST_NON_UM1AI126617_075 BELIEVE: BENCH TO BED ENHANCED LYMPHOCYTE INFUSIONS TO ENGINEER VIRAL ERADICATION - PROJECT ABSTRACT THIS NEW GRANT APPLICATION IS IN RESPONSE TO THE “MARTIN DELANEY COLLABORATORI… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | NEW YORK, NY-12 | 2024 | $27,854,913 |
ASST_NON_UM1AI164565_075 REACH: RESEARCH ENTERPRISE TO ADVANCE A CURE FOR HIV - MODIFIED PROJECT SUMMARY/ABSTRACT SECTION DESPITE THE SUCCESS OF STANDARD ANTIRETROVIRAL THERAPY (ART), THE NEED FOR AN HIV… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | NEW YORK, NY-12 | 2024 | $27,533,114 |
ASST_NON_K12HD000850_075 PEDIATRIC SCIENTIST DEVELOPMENT PROGRAM - PROJECT SUMMARY THE PEDIATRIC SCIENTIST DEVELOPMENT PROGRAM (PSDP) REMAINS COMMITTED TO BUILDING A DIVERSE NEXT GENERATION OF PEDIATRICIA… | Department of Health and Human Services National Institutes of Health | 93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | NY-90 | 2024 | $26,021,346 |
ASST_NON_P01HL114501_075 DISTINCT AND OVERLAPPING PATHWAYS OF FIBROSIS AND EMPHYSEMA IN CIGARETTE SMOKERS - PROJECT SUMMARY/ ABSTRACT CIGARETTE SMOKING IS THE GREATEST KNOWN SINGLE RISK FACTOR FOR THE DEV… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $24,868,053 |
ASST_NON_P01AI129859_075 IMMUNOLOGIC STRATEGIES TO PREVENT CONGENITAL CYTOMEGALOVIRUS TRANSMISSION AND DISEASE IN RHESUS MONKEYS - ABSTRACT - OVERALL CONGENITAL CYTOMEGALOVIRUS (CCMV) IS A PREVALENT IN UT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NY-90 | 2024 | $23,140,089 |
ASST_NON_P01AI117915_075 EARLY LIFE VACCINATION TO PREVENT HIV ACQUISITION DURING ADOLESCENCE - ABSTRACT – OVERALL NEARLY 600,000 NEW HIV INFECTIONS OCCUR YEARLY IN ADOLESCENTS/YOUNG ADULTS (AGES 15-24 YE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $21,162,960 |
ASST_NON_P30DA040500_075 HEALTH ECONOMICS OF SUBSTANCE USE DISORDER, HCV, AND HIV TREATMENT: SUPPORTING FINANCIAL SUSTAINABILITY, ADVANCED METHODS, AND KNOWLEDGE TRANSLATION - IN THE 10 YEARS SINCE OUR IN… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | NY-90 | 2024 | $16,293,676 |
ASST_NON_P01AI159402_075 TRANSMISSION AEROBIOLOGY OF M. TUBERCULOSIS: GENES AND METABOLIC PATHWAYS THAT SUSTAIN MTB ACROSS AN EVOLUTIONARY BOTTLENECK - ABSTRACT UNLESS COVID OVERTAKES IT, TUBERCULOSIS IS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $15,828,159 |
ASST_NON_P50AR070594_075 CENTER FOR LUPUS RESEARCH - THE COOPERATIVE CENTER OF RESEARCH TRANSLATION ENTITLED “CENTER FOR LUPUS RESEARCH” (CLR) AND BASED AT WEILL CORNELL MEDICINE AND JAX/GM AIMS I) TO ADV… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $15,274,546 |
ASST_NON_U19AI162568_075 DETERMINANTS OF TB CONTROL, RELAPSE AND REINFECTION - MYCOBACTERIUM TUBERCULOSIS (MTB), THE CAUSATIVE AGENT OF TUBERCULOSIS (TB), CONTINUES TO BE A SEVERE GLOBAL HEALTH PROBLEM. T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $13,020,010 |
ASST_NON_P01AI143575_075 PATHWAY ANALYSIS IN TUBERCULOSIS - OVERALL, ABSTRACT DESPITE THE AVAILABILITY OF THERAPY, MYCOBACTERIUM TUBERCULOSIS (MTB) IS THE MAJOR INFECTIOUS KILLER OF ADULTS. FINDING MORE E… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $12,320,237 |
ASST_NON_RM1HG011563_075 CENTER FOR GENOMIC INFORMATION ENCODED BY RNA NUCLEOTIDE MODIFICATIONS - POST-TRANSCRIPTIONAL MECHANISMS CONTROL GENE EXPRESSION IN VIRTUALLY EVERY CELL. A MAJOR MEDIATOR OF POST-… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | NEW YORK, NY-12 | 2024 | $12,143,189 |
ASST_NON_P01AG073090_075 CENTER FOR RESEARCH AND EDUCATION ON AGING AND TECHNOLOGY ENHANCEMENT - CREATE - PROJECT SUMMARY THE LANDSCAPE OF AGING AND TECHNOLOGY HAS CHANGED DRAMATICALLY. UPTAKE OF TECHNOLO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | NY-90 | 2024 | $12,069,399 |
ASST_NON_UH3HL145266_075 1/2 PROSPECTIVE TREATMENT EFFICACY IN IPF USLNG GENOTYPE FOR NAC SELECTION (PRECISIONS) TRIAL AND MOLECULAR ENDOPHENOTYPING IN IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL LUNG… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WORCESTER, MA-02 | 2024 | $11,649,214 |
ASST_NON_KL2TR002385_075 I. INSTITUTIONAL CAREER DEVELOPMENT CORE - THE MISSION OF THE INSTITUTIONAL CAREER DEVELOPMENT CORE (KL2) IS TO TRAIN, MENTOR, AND DEVELOP THE NEXT GENERATION OF SKILLED, INDEPEND… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | NEW YORK, NY-12 | 2024 | $11,551,118 |
ASST_NON_P30AG022845_075 CORNELL ROYBAL CENTER-TRANSLATIONAL RESEARCH INSTITUTE ON PAIN IN LATER LIFE - OVER THE PAST 5 YEARS, CORNELL’S ROYBAL CENTER–THE TRANSLATIONAL RESEARCH INSTITUTE ON PAIN IN LATER… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | NY-90 | 2024 | $11,394,132 |
ASST_NON_R01HL144718_075 UNDERSTANDING THE ORIGINS OF EARLY COPD - ABSTRACT THE FUNDAMENTAL GAP EXISTING IN UNDERSTANDING THE ORIGINS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS CENTRALLY RESPONSI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WORCESTER, MA-02 | 2024 | $11,273,630 |
ASST_NON_U01AI095608_075 MIST EARLY CAREER SCHOLAR AWARDS IN MUCOSAL IMMUNOLOGY - PROJECT ABSTRACT THE IMMUNE SYSTEM AT MUCOSAL SITES MUST BE TIGHTLY REGULATED TO MEDIATE RAPID IMMUNITY TO INVADING PATHOG… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $10,994,986 |
ASST_NON_P50CA211024_075 WEILL CORNELL MEDICINE (WCM) SPORE IN PROSTATE CANCER - OVERALL SUMMARY PROSTATE CANCER (PCA) IS ONE OF THE MOST COMMON CANCERS IN THE WESTERN HEMISPHERE, WITH EXTREME CLINICAL AN… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | NEW YORK, NY-12 | 2024 | $10,877,787 |
ASST_NON_U54NS100717_075 LINKING TAU PROTEOSTASIS WITH NEURONAL ACTIVITY IN FTD - ABSTRACT — OVERALL COMPONENT NEURODEGENERATIVE TAUOPATHIES, INCLUDING ALZHEIMER'S DISEASE (AD) AND FRONTOTEMPORAL LOBAR DE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | NEW YORK, NY-12 | 2024 | $10,820,367 |
ASST_NON_R01HL136682_075 THE CAPTURE STUDY: VALIDATING A UNIQUE COPD SCREENING TOOL IN PRIMARY CARE - PROJECT SUMMARY/ABSTRACT MOST COPD PATIENTS REMAIN UNRECOGNIZED AND UNDERTREATED; THESE INDIVIDUALS E… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NY-90 | 2025 | $10,644,009 |
ASST_NON_R35CA197730_075 BEHAVIORAL AND PSYCHOSOCIAL EFFECTS ON STUDY OUTCOMES IN END-STAGE CANCER TREATMENT (BEST END-STAGE CANCER STUDY) - DESPITE GREAT STRIDES THAT HAVE BEEN MADE IN THE UNDERSTANDING… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | NEW YORK, NY-12 | 2024 | $10,387,681 |
ASST_NON_R01GM051405_075 SIGNAL TRANSDUCTION TO P70 S6 KINASE 1 - SUMMARY A CONTINUOUS CHALLENGE FOR BOTH SINGLE CELLS AND MULTICELLULAR ORGANISMS IS THAT THE AVAILABILITY OF NUTRIENTS IS FLUCTUATING CONS… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | NY-90 | 2025 | $9,817,515 |
ASST_NON_U54CA242639_075 PARTNERSHIP FOR PREVENTION OF HPV-ASSOCIATED CANCERS IN PEOPLE LIVING WITH HIV: BRAZIL, MEXICO, AND PUERTO RICO - OVERALL ABSTRACT THE PARTNERSHIP CENTER, ENTITLED MULTINATIONAL P… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | NY-90 | 2024 | $9,410,306 |
ASST_NON_R01CA046595_075 MITOGENIC AND ONCOGENIC REGULATION OF ERK/RSK SIGNALING - CANCER IS THE 2ND LEADING CAUSE OF DEATH IN THE US. THE ADVENT OF NEW TREATMENTS SUCH AS IMMUNOTHERAPY AND TARGETED THERA… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | NEW YORK, NY-12 | 2024 | $9,203,389 |
ASST_NON_T32CA062948_075 CANCER PHARMACOLOGY - FACULTY FROM TWO INSTITUTIONS, WEILL CORNELL MEDICINE ((WCM), FORMERLY, WEILL CORNELL MEDICAL COLLEGE (WCMC)), AND MEMORIAL SLOAN-KETTERING CANCER CENTER (MS… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | NEW YORK, NY-12 | 2024 | $9,132,205 |
ASST_NON_W81XWH1810667_097 A PHASE 2 STUDY OF INHALED CO FOR THE TREATMENT OF ARDS THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE INTO THE AWARD TERMS AND CONDITIONS A STOP WORK ORDER, AT THE DIRECTION… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | NEW YORK, NY-12 | 2024 | $8,914,310 |
ASST_NON_P01CA214274_075 MECHANISM-BASED TARGETING OF MANTLE CELL LYMPHOMA - MANTLE CELL LYMPHOMA (MCL) IS A NON-HODGKIN LYMPHOMA THAT REMAINS INCURABLE DUE TO THE DEVELOPMENT OF DRUG RESISTANCE, DESPITE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | NY-90 | 2024 | $8,906,095 |
ASST_NON_U19AI144301_075 IMMUNE CELLS AND SECRETORY PATHWAYS LEADING TO HUMAN SYSTEMIC AUTOIMMUNITY - SUMMARY OVERALL; PD – PASCUAL, V. THE AUTOIMMUNITY CENTER OF EXCELLENCE BASED AT WEILL CORNELL MEDICIN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $8,537,093 |
ASST_NON_R01HL165452_075 REASONS FOR GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE-MYOCARDIAL INFARCTION-4 (REGARDS-MI-4) - CORONARY HEART DISEASE (CHD) AND HEART FAILURE (HF) DISPARITIES PERSIST IN THE US… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $8,345,645 |
ASST_NON_P01AI131276_075 THE ORIGIN, PREDICTORS, AND IMMUNE CORRELATES OF VIRAL REBOUND IN ORALLY SHIV INFECTED INFANT MONKEYS - ABSTRACT – OVERALL (SALLIE PERMAR, PI; DUKE UNIVERSITY) ALMOST 2 MILLION CH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $8,191,701 |
ASST_NON_C06OD036045_075 MODERNIZATION AND EXPANSION OF THE CITIGROUP BIOMEDICAL IMAGING CENTER AT WEILL CORNELL MEDICAL COLLEGE - ABSTRACT THE PROPOSED PROJECT INVOLVES MAJOR MODERNIZATION AND FOCUSED CO… | Department of Health and Human Services National Institutes of Health | 93.352 CONSTRUCTION SUPPORT | NEW YORK, NY-12 | 2025 | $8,000,000 |
ASST_NON_R01NS037853_075 ALZHEIMER PATHOLOGY AND NEUROVASCULAR DYSFUNCTION - ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/ADRD) ARE LEADING CAUSES OF AGE-RELATED COGNITIVE IMPAIRMENT, CURRENTLY UNTREATAB… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | NEW YORK, NY-12 | 2024 | $7,921,711 |
ASST_NON_R01HL143788_075 A LONGITUDINAL COHORT STUDY TO EVALUATE CARDIOVASCULAR RISK FACTORS AND DISEASE IN HAITI - 2 - ABSTRACT: CARDIOVASCULAR DISEASE (CVD) IS THE LEADING CAUSE OF DEATH GLOBALLY, WITH… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NY-90 | 2024 | $7,692,108 |
ASST_NON_R35NS111631_075 NEW MECHANISMS AND TECHNOLOGIES FOR UNDERSTANDING POST-TRANSCRIPTIONAL GENE REGULATION IN NEURONS - THE OVERALL GOAL OF OUR RESEARCH PROGRAM IS TO UNDERSTAND THE INTRICATE MECHANI… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | NEW YORK, NY-12 | 2024 | $7,516,261 |
ASST_NON_R35GM127026_075 CELL SIGNALING AND CELL DECISIONS - PROJECT SUMMARY/ABSTRACT MAMMALIAN CELLS MUST MOVE AND PROLIFERATE TO MAINTAIN AND REGENERATE TISSUES AND DEFEND THEMSELVES AGAINST PATHOGENS,… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | NY-90 | 2024 | $7,509,172 |
ASST_NON_R01GM058055_075 SYNAPTIC MECHANISMS OF GENERAL ANESTHETIC ACTION - ABSTRACT DESPITE WIDESPREAD CLINICAL USE, KNOWLEDGE OF THE MECHANISMS OF GENERAL ANESTHETICS IS INSUFFICIENT TO EXPLAIN HOW THEY… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | NY-90 | 2025 | $7,214,938 |
ASST_NON_R01AG057681_075 THE LUCINDA TRIAL - PROJECT SUMMARY THIS PROJECT AIMS TO RE-PURPOSE THE SAFE AND WELL-TOLERATED GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOGUE LUPRON FOR USE IN ALZHEIMER'S DISEAS… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | NY-90 | 2024 | $7,212,214 |
ASST_NON_R35CA220499_075 TARGETING EPIGENETIC CIRCUITS IN B-CELL LYMPHOMAS - ABSTRACT THE PRINCIPAL INVESTIGATOR IS A PHYSICIAN SCIENTIST WHO HAS CONTRIBUTED SIGNIFICANT DISCOVERIES TO THE CANCER EPIGENET… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | NY-90 | 2024 | $7,170,521 |
ASST_NON_U01DA058527_075 ELUCIDATING SINGLE CELL CHANGES IN NEUROGENIC BRAIN REGIONS DURING HIV AND CANNABINOID EXPOSURE - PROJECT SUMMARY (ABSTRACT) THE USE OF CANNABIS FOR RECREATION AND MEDICINAL PURPO… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | NEW YORK, NY-12 | 2024 | $7,084,951 |
ASST_NON_R35CA232093_075 SYSTEMIC REGULATION OF METASTASIS - PROJECT SUMMARY CANCER IS A SYSTEMIC DISEASE. ITS GROWTH AND MALIGNANT PROGRESSION RELIES NOT ONLY ON THE INTRINSIC ABERRANT GENETIC AND EPIGEN… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | NY-90 | 2024 | $6,962,391 |
ASST_NON_U01HD116260_075 OPTIMIZING PAIN TREATMENT IN CHILDREN ON MECHANICAL VENTILATION (OPTICOM) - PROJECT SUMMARY/ABSTRACT MORE THAN 24,000 CHILDREN DEVELOP ACUTE RESPIRATORY FAILURE (ARF) AND REQUIRE… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | NY-90 | 2024 | $6,866,353 |
ASST_NON_UH3NS095554_075 CENTRAL THALAMIC STIMULATION FOR TRAUMATIC BRAIN INJURY - DESCRIPTION (PROVIDED BY APPLICANT): SEVERE TO MODERATE TRAUMATIC BRAIN INJURY (SMTBI) ANNUALLY AFFLICTS MANY HUNDR… | Department of Health and Human Services National Institutes of Health | 93.372 21ST CENTURY CURES ACT - BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES | NY-90 | 2024 | $6,861,988 |
ASST_NON_R01HL093324_075 MACROPHAGE-LIPOPROTEIN INTERACTIONS - AGGREGATES OF LIPOPROTEINS THAT ARE TIGHTLY CROSSLINKED TO THE EXTRACELLULAR MATRIX ARE THE MAJOR TYPE OF LIPOPROTEIN IN ATHEROSCLEROTIC LESI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $6,689,427 |
ASST_NON_R01HL111724_075 ANATOMY OF THE CIRCLE OF WILLIS, CEREBRAL BLOOD FLOW, AND ALZHEIMER'S DISEASE BIOMARKERS IN HYPERTENSION - SUMMARY HYPERTENSION (HTN), AFFECTS OVER 60% OF US POPULATION ABOVE 60.… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $6,569,617 |
ASST_NON_W81XWH2120034_097 THERAPEUTIC TARGETING OF BREAST CANCER AND HOST IMMUNE RESPONSES AT INFLECTION POINTS IN THE DISEASE TRAJECTORY INCORPORATE STOP WORK ORDER 1. PER SECTION 711 OF THE NATIONAL DEFE… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | NEW YORK, NY-12 | 2025 | $6,552,437 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$393.7M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$252.6M
93.866 — AGING RESEARCH$213.1M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$150.2M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$144.0M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$139.8M
93.396 — CANCER BIOLOGY RESEARCH$121.6M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$114.5M
93.242 — MENTAL HEALTH RESEARCH GRANTS$101.0M
93.350 — NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES$93.6M
Source: USAspending.gov · All Recipients · Vermont